Table 3.
N | k | r | 95% CI | 80% CR | Q | I2 | |
Overall relationship | 1390 | 31 | 0.28* | (0.20 to 0.35) | (0.09 to 0.45) | 53.7* | 46.0 |
Team characteristics | |||||||
Professional composition | |||||||
Interprofessional | 1264 | 27 | 0.28* | (0.20 to 0.36) | (0.09 to 0.46) | 47.1* | 48.2 |
Uniprofessional | 126 | 4 | 0.28 | (−0.01 to 0.52) | (−0.04 to 0.54) | 6.5 | 47.1 |
Team familiarity | |||||||
Experimental team | 240 | 10 | 0.25* | (0.05 to 0.43) | (−0.05 to 0.51) | 17.2* | 47.2 |
Real team | 1150 | 21 | 0.29* | (0.20 to 0.37) | (0.12 to 0.45) | 36.2* | 45.7 |
Team size† | |||||||
Task characteristics | |||||||
Task type | |||||||
Routine task | 766 | 14 | 0.27* | (0.12 to 0.40) | (−0.01 to 0.50) | 30.9* | 65.0 |
Non-routine task | 609 | 16 | 0.29* | (0.20 to 0.39) | (0.16 to 0.42) | 20.5 | 24.6 |
Methodological factors | |||||||
Patient realism | |||||||
Real patient | 993 | 16 | 0.28* | (0.18 to 0.38) | (0.10 to 0.45) | 28.7* | 49.3 |
Simulated patient | 397 | 15 | 0.28* | (0.13 to 0.41) | (0.02 to 0.50) | 25.0* | 44.6 |
Performance measures | |||||||
Outcome performance | 390 | 4 | 0.13* | (0.03 to 0.23) | (0.06 to 0.19) | 1.3 | 0.0 |
Process performance | 1000 | 27 | 0.30* | (0.21 to 0.39) | (0.10 to 0.49) | 45.6* | 45.6 |
*p < .05.
I2 = % of total variability in the effect size estimates due to heterogeneity among true effects (vs sampling error).
†Team size was entered as a continuous variable, therefore, no subgroup analyses exist.
CI, confidence interval; CR, credibility interval; K, number of studies; N, cumulative sample size (number of teams); Q, test statistic for residual heterogeneity of the models; r, sample-size weighted correlation.